Four things to know:
1. Conformis entered into a licensing agreement for its patient-specific joint replacement instrumentation technology with Stryker. Stryker paid $14 million upfront, and could make up to $16 million in additional payments upon achieving certain milestones.
2. With this agreement, the companies will collaborate to design, manufacture and commercialize patient-specific instrumentation for use with Stryker’s knee offerings, including the Triathlon total knee system.
3. The two companies also entered into a distribution agreement for Conformis to provide Stryker with patient-specific instrumentation. Conformis retains all IP for patient-specific implants.
4. Conformis’ proprietary technology uses a CT-based 3D model to create disposable instrumentation for joint replacement procedures.
Editors Note: This article was updated at 4:25 pm CST to reflect that Stryker entered into a licensing agreement for patient-specific instrumentation, not patient-specific implants. Conformis will retain all IP for patient-specific implants.
More articles on orthopedics:
NuVasive aims to grow in robotics with new application
Zimmer Biomet adds to leadership ranks
Brainlab unveils mobile intraoperative robot for spine surgery
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.